Literature DB >> 9465082

Deletion of Plasmodium berghei-specific CD4+ T cells adoptively transferred into recipient mice after challenge with homologous parasite.

C Hirunpetcharat1, M F Good.   

Abstract

The immune response to malaria parasites includes T cell responses that reduce parasites by effector T cell responses and by providing help for antibody responses. Some parasites are more sensitive to antibody and others are more sensitive to cell-mediated immunity. We demonstrate that cultured CD4(+) T cells that produce interferon gamma and interleukin 2, but not interleukin 4, in response to stimulation with the rodent parasite Plasmodium berghei can reduce but not eliminate parasites in vivo after adoptive transfer. Although cells can persist in vivo for up to 9 months in uninfected mice, infection results in elimination of up to 99% of specific T cells in different tissues, as judged by tracking T cells labeled with the fluorescent dye 5-(and -6)-carboxyfluorescein diacetate succinimidyl ester. T cells specific for ovalbumin are unaffected. In vivo activation and division of transferred T cells per se are not responsible for deletion because T cells positive for 5-(and -6)-carboxyfluorescein diacetate succinimidyl ester divide up to six times within 7 days in uninfected mice and are not deleted. Understanding the factors responsible for parasite-mediated specific deletion of T cells would enhance our knowledge of parasite immunity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9465082      PMCID: PMC19161          DOI: 10.1073/pnas.95.4.1715

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Roles of CD4- and CD8-bearing T lymphocytes in the immune response to the erythrocytic stages of Plasmodium chabaudi.

Authors:  G Süss; K Eichmann; E Kury; A Linke; J Langhorne
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

2.  Interdependence of CD4+ T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development.

Authors:  S Kumar; M F Good; F Dontfraid; J M Vinetz; L H Miller
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

3.  Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S).

Authors:  J Hu-Li; J Ohara; C Watson; W Tsang; W E Paul
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

Review 4.  Cellular mechanisms of immunologic tolerance.

Authors:  G J Nossal
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

5.  Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa.

Authors:  B M Greenwood; A K Bradley; A M Greenwood; P Byass; K Jammeh; K Marsh; S Tulloch; F S Oldfield; R Hayes
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

6.  Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo.

Authors:  B Rocha; N Dautigny; P Pereira
Journal:  Eur J Immunol       Date:  1989-05       Impact factor: 5.532

7.  Inhibition of B lymphocyte activation by interferon-gamma.

Authors:  D S Reynolds; W H Boom; A K Abbas
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

8.  Plasmodium falciparum schizont sonic extracts suppress lymphoproliferative responses to mitogens and antigens in malaria-immune adults.

Authors:  E M Riley; O Jobe; M Blackman; H C Whittle; B M Greenwood
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

9.  Adoptive protection against Plasmodium chabaudi adami malaria in athymic nude mice by a cloned T cell line.

Authors:  D A Brake; C A Long; W P Weidanz
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

10.  Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.

Authors:  G L Spitalny; E A Havell
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

View more
  24 in total

1.  The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria.

Authors:  Morris O Makobongo; George Riding; Huji Xu; Chakrit Hirunpetcharat; Dianne Keough; John de Jersey; Peter Willadsen; Michael F Good
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

2.  Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1.

Authors:  Jiraprapa Wipasa; Huji Xu; Morris Makobongo; Michelle Gatton; Anthony Stowers; Michael F Good
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Early cytokine production is associated with protection from murine cerebral malaria.

Authors:  Andrew J Mitchell; Anna M Hansen; Leia Hee; Helen J Ball; Sarah M Potter; John C Walker; Nicholas H Hunt
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 4.  The contribution of Plasmodium chabaudi to our understanding of malaria.

Authors:  Robin Stephens; Richard L Culleton; Tracey J Lamb
Journal:  Trends Parasitol       Date:  2011-11-17

5.  Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria.

Authors:  Salenna R Elliott; Rachel D Kuns; Michael F Good
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.

Authors:  Catherine Q Nie; Nicholas J Bernard; Louis Schofield; Diana S Hansen
Journal:  Infect Immun       Date:  2007-02-26       Impact factor: 3.441

7.  Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1.

Authors:  Salenna R Elliott; Timothy P Spurck; Joelle M Dodin; Alexander G Maier; Till S Voss; Francisca Yosaatmadja; Paul D Payne; Geoffrey I McFadden; Alan F Cowman; Stephen J Rogerson; Louis Schofield; Graham V Brown
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

8.  Baculovirus-based nasal drop vaccine confers complete protection against malaria by natural boosting of vaccine-induced antibodies in mice.

Authors:  Shigeto Yoshida; Hitomi Araki; Takashi Yokomine
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

9.  Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria.

Authors:  Robin Stephens; Jean Langhorne
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

Review 10.  Recent advances on T-cell exhaustion in malaria infection.

Authors:  Esaki M Shankar; R Vignesh; A P Dash
Journal:  Med Microbiol Immunol       Date:  2018-06-23       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.